ContextVision – new CFO appointed
Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the same role at Inify Laboratories, a spinoff from ContextVision. Mrs Linderoth will remain within the company during a period to ensure a seamless transition.
Mr Hökerberg previously served as Chief Financial Officer at SIWI (Stockholm International Water institute) and prior to his time at SIWI, he held diverse roles in finance and accounting at IFL, Teracom, Eltel and Aleris. He received bachelor’s degree in business and accounting from University of Stockholm.
In Mr Hökerberg’s role as CFO, he will oversee financial reporting, accounting, tax, treasury, risk management and financial planning and analysis.
Fredrik Palm, the Company’s Chief Executive Officer, commented, “Great to have Markus being part of the ContextVision team and we look forward to benefit from his experience in our exciting growth plans for the future”.
“I am excited to step into the CFO role and be part of the ContextVision team. I look forward to help the Company to execute its strategic plan and deliver value for its shareholders”, said Mr. Hökerberg.
###
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
This information is information that ContextVision is obliged to make public pursuant to the EU Market Abuse Regulation.
###
For further information, please contact ContextVision's CEO, Fredrik Palm, at fredrik.palm@contextvision.se, or visit www.contextvision.com
###
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X- ray and MRI equipment around the world.
Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.